Guidelines of care for the management of basal cell carcinoma
- PMID: 29331385
- DOI: 10.1016/j.jaad.2017.10.006
Guidelines of care for the management of basal cell carcinoma
Abstract
Basal cell carcinoma (BCC) is the most common form of human cancer, with a continually increasing annual incidence in the United States. When diagnosed early, the majority of BCCs are readily treated with office-based therapy, which is highly curative. In these evidence-based guidelines of care, we provide recommendations for the management of patients with BCC, as well as an in-depth review of the best available literature in support of these recommendations. We discuss biopsy techniques for a clinically suspicious lesion and offer recommendations for the histopathologic interpretation of BCC. In the absence of a formal staging system, the best available stratification based on risk for recurrence is reviewed. With regard to treatment, we provide recommendations on treatment modalities along a broad therapeutic spectrum, ranging from topical agents and superficially destructive modalities to surgical techniques and systemic therapy. Finally, we review the available literature and provide recommendations on prevention and the most appropriate follow-up for patients in whom BCC has been diagnosed.
Keywords: basal cell carcinoma; biopsy; curettage; metastasis; phototherapy; radiotherapy; staging; surgery; surveillance; topical therapy.
Copyright © 2017 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Comment in
-
Comment on "Guidelines of care for the management of basal cell carcinoma".J Am Acad Dermatol. 2018 Nov;79(5):e99-e100. doi: 10.1016/j.jaad.2018.05.1261. Epub 2018 Jul 5. J Am Acad Dermatol. 2018. PMID: 29981387 No abstract available.
-
Reply to: "Comment on 'Guidelines of care for the management of basal cell carcinoma'".J Am Acad Dermatol. 2018 Nov;79(5):e101. doi: 10.1016/j.jaad.2018.06.051. Epub 2018 Jul 5. J Am Acad Dermatol. 2018. PMID: 29981388 No abstract available.
Similar articles
-
Guidelines of care for the management of cutaneous squamous cell carcinoma.J Am Acad Dermatol. 2018 Mar;78(3):560-578. doi: 10.1016/j.jaad.2017.10.007. Epub 2018 Jan 10. J Am Acad Dermatol. 2018. PMID: 29331386 Free PMC article.
-
Treatment of Basal Cell Carcinoma in the Elderly: What Nondermatologists Need to Know.Am J Med. 2016 Jul;129(7):655-60. doi: 10.1016/j.amjmed.2016.03.003. Epub 2016 Apr 1. Am J Med. 2016. PMID: 27046242 Review.
-
Basal cell carcinoma-treatments for the commonest skin cancer.Dtsch Arztebl Int. 2014 May 30;111(22):389-95. doi: 10.3238/arztebl.2014.0389. Dtsch Arztebl Int. 2014. PMID: 24980564 Free PMC article. Review.
-
Update of the European guidelines for basal cell carcinoma management.Eur J Dermatol. 2014 May-Jun;24(3):312-29. doi: 10.1684/ejd.2014.2271. Eur J Dermatol. 2014. PMID: 24723647
-
Identifying patients at risk for recurrent or advanced BCC.J Drugs Dermatol. 2013 Nov;12(11):1246-52; quiz 1253-4. J Drugs Dermatol. 2013. PMID: 24196332
Cited by
-
A Case of Metastatic Basal Cell Carcinoma (BCC) With Spinal and Pulmonary Metastases Treated With Vismodegib, Sonedigib, and Radiotherapy.Cureus. 2022 Mar 17;14(3):e23273. doi: 10.7759/cureus.23273. eCollection 2022 Mar. Cureus. 2022. PMID: 35449646 Free PMC article.
-
Curettage and electrocoagulation versus surgical excision in the treatment of low-risk basal cell carcinoma - Postoperative follow-up and satisfaction at three months: randomized clinical trial.An Bras Dermatol. 2022 May-Jun;97(3):384-386. doi: 10.1016/j.abd.2020.12.011. Epub 2022 Feb 28. An Bras Dermatol. 2022. PMID: 35241317 Free PMC article. Clinical Trial. No abstract available.
-
Depth of Invasion of Aggressive and Nonaggressive Basal Cell Carcinoma.J Clin Aesthet Dermatol. 2019 Mar;12(3):12-14. Epub 2019 Mar 1. J Clin Aesthet Dermatol. 2019. PMID: 30988868 Free PMC article.
-
Non-syndromic Unilateral Basal Cell Carcinomas: A Case Report and Literature Review.Acta Derm Venereol. 2020 Mar 31;100(6):adv00101. doi: 10.2340/00015555-3462. Acta Derm Venereol. 2020. PMID: 32189006 Free PMC article. Review. No abstract available.
-
Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma.Oncotarget. 2021 Sep 28;12(20):2089-2100. doi: 10.18632/oncotarget.28080. eCollection 2021 Sep 28. Oncotarget. 2021. PMID: 34611482 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical